nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—CYP2D6—Lomustine—brain cancer	0.224	0.282	CbGbCtD
Mirabegron—CYP2D6—Hydroxyurea—brain cancer	0.17	0.213	CbGbCtD
Mirabegron—CYP3A4—Temozolomide—brain cancer	0.168	0.211	CbGbCtD
Mirabegron—CYP3A4—Lomustine—brain cancer	0.143	0.179	CbGbCtD
Mirabegron—ABCB1—Etoposide—brain cancer	0.0576	0.0722	CbGbCtD
Mirabegron—CYP3A4—Etoposide—brain cancer	0.0345	0.0433	CbGbCtD
Mirabegron—Lung neoplasm malignant—Procarbazine—brain cancer	0.0225	0.112	CcSEcCtD
Mirabegron—Neoplasm—Lomustine—brain cancer	0.00643	0.0321	CcSEcCtD
Mirabegron—Osteoarthritis—Lomustine—brain cancer	0.00516	0.0258	CcSEcCtD
Mirabegron—Vascular purpura—Procarbazine—brain cancer	0.00366	0.0183	CcSEcCtD
Mirabegron—Purpura—Procarbazine—brain cancer	0.0034	0.017	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00332	0.0166	CcSEcCtD
Mirabegron—Neoplasm—Hydroxyurea—brain cancer	0.00316	0.0158	CcSEcCtD
Mirabegron—Infection—Carboplatin—brain cancer	0.00288	0.0144	CcSEcCtD
Mirabegron—Propafenone—CYP2C9—brain cancer	0.00262	1	CrCbGaD
Mirabegron—Vaginal infection—Temozolomide—brain cancer	0.00258	0.0129	CcSEcCtD
Mirabegron—Neoplasm—Carmustine—brain cancer	0.00255	0.0128	CcSEcCtD
Mirabegron—Dry eye—Temozolomide—brain cancer	0.00252	0.0126	CcSEcCtD
Mirabegron—Infection—Lomustine—brain cancer	0.00252	0.0126	CcSEcCtD
Mirabegron—Neoplasm—Temozolomide—brain cancer	0.00247	0.0123	CcSEcCtD
Mirabegron—Breast disorder—Hydroxyurea—brain cancer	0.00229	0.0114	CcSEcCtD
Mirabegron—Vascular purpura—Temozolomide—brain cancer	0.00222	0.0111	CcSEcCtD
Mirabegron—Purpura—Temozolomide—brain cancer	0.00206	0.0103	CcSEcCtD
Mirabegron—Infestation NOS—Hydroxyurea—brain cancer	0.00195	0.00976	CcSEcCtD
Mirabegron—Infestation—Hydroxyurea—brain cancer	0.00195	0.00976	CcSEcCtD
Mirabegron—Breast disorder—Temozolomide—brain cancer	0.00179	0.00894	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00178	0.00891	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00175	0.00873	CcSEcCtD
Mirabegron—Abdominal distension—Temozolomide—brain cancer	0.00172	0.00861	CcSEcCtD
Mirabegron—Hypertension—Procarbazine—brain cancer	0.0017	0.00851	CcSEcCtD
Mirabegron—Arthralgia—Procarbazine—brain cancer	0.00168	0.00839	CcSEcCtD
Mirabegron—Dry mouth—Procarbazine—brain cancer	0.00164	0.00821	CcSEcCtD
Mirabegron—Infection—Procarbazine—brain cancer	0.0016	0.00799	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Temozolomide—brain cancer	0.00159	0.00795	CcSEcCtD
Mirabegron—Tachycardia—Procarbazine—brain cancer	0.00157	0.00785	CcSEcCtD
Mirabegron—Urinary tract infection—Carmustine—brain cancer	0.00154	0.00767	CcSEcCtD
Mirabegron—Infestation—Temozolomide—brain cancer	0.00153	0.00762	CcSEcCtD
Mirabegron—Infestation NOS—Temozolomide—brain cancer	0.00153	0.00762	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00151	0.00756	CcSEcCtD
Mirabegron—Nausea—Lomustine—brain cancer	0.00151	0.00752	CcSEcCtD
Mirabegron—Urinary tract infection—Temozolomide—brain cancer	0.00148	0.00741	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00147	0.00733	CcSEcCtD
Mirabegron—Sinusitis—Temozolomide—brain cancer	0.00143	0.00715	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Etoposide—brain cancer	0.0014	0.00698	CcSEcCtD
Mirabegron—Connective tissue disorder—Carmustine—brain cancer	0.00139	0.00696	CcSEcCtD
Mirabegron—Fatigue—Procarbazine—brain cancer	0.00139	0.00693	CcSEcCtD
Mirabegron—Constipation—Procarbazine—brain cancer	0.00138	0.00688	CcSEcCtD
Mirabegron—Urinary tract disorder—Temozolomide—brain cancer	0.00135	0.00676	CcSEcCtD
Mirabegron—Connective tissue disorder—Temozolomide—brain cancer	0.00135	0.00673	CcSEcCtD
Mirabegron—Urethral disorder—Temozolomide—brain cancer	0.00134	0.00671	CcSEcCtD
Mirabegron—Eye disorder—Carmustine—brain cancer	0.00133	0.00662	CcSEcCtD
Mirabegron—Gastrointestinal pain—Procarbazine—brain cancer	0.00132	0.00658	CcSEcCtD
Mirabegron—Erythema multiforme—Temozolomide—brain cancer	0.0013	0.00647	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00129	0.00645	CcSEcCtD
Mirabegron—Eye disorder—Temozolomide—brain cancer	0.00128	0.0064	CcSEcCtD
Mirabegron—Urticaria—Procarbazine—brain cancer	0.00128	0.00639	CcSEcCtD
Mirabegron—Abdominal pain—Procarbazine—brain cancer	0.00127	0.00636	CcSEcCtD
Mirabegron—Cardiac disorder—Temozolomide—brain cancer	0.00127	0.00635	CcSEcCtD
Mirabegron—Infection—Hydroxyurea—brain cancer	0.00124	0.00618	CcSEcCtD
Mirabegron—Infestation NOS—Etoposide—brain cancer	0.00122	0.0061	CcSEcCtD
Mirabegron—Infestation—Etoposide—brain cancer	0.00122	0.0061	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00121	0.00605	CcSEcCtD
Mirabegron—Skin disorder—Hydroxyurea—brain cancer	0.00121	0.00605	CcSEcCtD
Mirabegron—Back pain—Carmustine—brain cancer	0.00119	0.00596	CcSEcCtD
Mirabegron—Vision blurred—Carmustine—brain cancer	0.00116	0.00581	CcSEcCtD
Mirabegron—Asthenia—Procarbazine—brain cancer	0.00116	0.00577	CcSEcCtD
Mirabegron—Back pain—Temozolomide—brain cancer	0.00115	0.00576	CcSEcCtD
Mirabegron—Pruritus—Procarbazine—brain cancer	0.00114	0.00569	CcSEcCtD
Mirabegron—Vision blurred—Temozolomide—brain cancer	0.00112	0.00562	CcSEcCtD
Mirabegron—Diarrhoea—Procarbazine—brain cancer	0.0011	0.0055	CcSEcCtD
Mirabegron—Dyspepsia—Hydroxyurea—brain cancer	0.0011	0.00548	CcSEcCtD
Mirabegron—Urinary tract disorder—Etoposide—brain cancer	0.00108	0.00541	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00108	0.00537	CcSEcCtD
Mirabegron—Urethral disorder—Etoposide—brain cancer	0.00108	0.00537	CcSEcCtD
Mirabegron—Fatigue—Hydroxyurea—brain cancer	0.00107	0.00537	CcSEcCtD
Mirabegron—Hypertension—Carmustine—brain cancer	0.00107	0.00532	CcSEcCtD
Mirabegron—Constipation—Hydroxyurea—brain cancer	0.00107	0.00532	CcSEcCtD
Mirabegron—Dizziness—Procarbazine—brain cancer	0.00107	0.00532	CcSEcCtD
Mirabegron—Palpitations—Temozolomide—brain cancer	0.00105	0.00527	CcSEcCtD
Mirabegron—Erythema multiforme—Etoposide—brain cancer	0.00104	0.00518	CcSEcCtD
Mirabegron—Hypertension—Temozolomide—brain cancer	0.00103	0.00514	CcSEcCtD
Mirabegron—Eye disorder—Etoposide—brain cancer	0.00103	0.00512	CcSEcCtD
Mirabegron—Cardiac disorder—Etoposide—brain cancer	0.00102	0.00508	CcSEcCtD
Mirabegron—Arthralgia—Temozolomide—brain cancer	0.00102	0.00507	CcSEcCtD
Mirabegron—Rash—Procarbazine—brain cancer	0.00102	0.00507	CcSEcCtD
Mirabegron—Dermatitis—Procarbazine—brain cancer	0.00101	0.00507	CcSEcCtD
Mirabegron—Headache—Procarbazine—brain cancer	0.00101	0.00504	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00101	0.00504	CcSEcCtD
Mirabegron—Infection—Carmustine—brain cancer	0.001	0.005	CcSEcCtD
Mirabegron—Dry mouth—Temozolomide—brain cancer	0.000994	0.00496	CcSEcCtD
Mirabegron—Tachycardia—Carmustine—brain cancer	0.000984	0.00491	CcSEcCtD
Mirabegron—Infection—Temozolomide—brain cancer	0.000968	0.00483	CcSEcCtD
Mirabegron—Nausea—Procarbazine—brain cancer	0.000957	0.00478	CcSEcCtD
Mirabegron—Skin disorder—Temozolomide—brain cancer	0.000946	0.00472	CcSEcCtD
Mirabegron—Back pain—Etoposide—brain cancer	0.000924	0.00461	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Carmustine—brain cancer	0.000918	0.00458	CcSEcCtD
Mirabegron—Asthenia—Hydroxyurea—brain cancer	0.000894	0.00447	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000887	0.00443	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Carmustine—brain cancer	0.00087	0.00434	CcSEcCtD
Mirabegron—Constipation—Carmustine—brain cancer	0.000862	0.0043	CcSEcCtD
Mirabegron—Dyspepsia—Temozolomide—brain cancer	0.000857	0.00428	CcSEcCtD
Mirabegron—Diarrhoea—Hydroxyurea—brain cancer	0.000853	0.00426	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Temozolomide—brain cancer	0.000841	0.0042	CcSEcCtD
Mirabegron—Fatigue—Temozolomide—brain cancer	0.00084	0.00419	CcSEcCtD
Mirabegron—Constipation—Temozolomide—brain cancer	0.000833	0.00416	CcSEcCtD
Mirabegron—Hypertension—Etoposide—brain cancer	0.000824	0.00412	CcSEcCtD
Mirabegron—Dizziness—Hydroxyurea—brain cancer	0.000824	0.00412	CcSEcCtD
Mirabegron—Gastrointestinal pain—Carmustine—brain cancer	0.000824	0.00411	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000807	0.00403	CcSEcCtD
Mirabegron—Abdominal pain—Carmustine—brain cancer	0.000797	0.00398	CcSEcCtD
Mirabegron—Gastrointestinal pain—Temozolomide—brain cancer	0.000796	0.00398	CcSEcCtD
Mirabegron—Rash—Hydroxyurea—brain cancer	0.000786	0.00392	CcSEcCtD
Mirabegron—Dermatitis—Hydroxyurea—brain cancer	0.000785	0.00392	CcSEcCtD
Mirabegron—Headache—Hydroxyurea—brain cancer	0.000781	0.0039	CcSEcCtD
Mirabegron—Infection—Etoposide—brain cancer	0.000774	0.00387	CcSEcCtD
Mirabegron—Urticaria—Temozolomide—brain cancer	0.000774	0.00386	CcSEcCtD
Mirabegron—Abdominal pain—Temozolomide—brain cancer	0.00077	0.00384	CcSEcCtD
Mirabegron—Tachycardia—Etoposide—brain cancer	0.000761	0.0038	CcSEcCtD
Mirabegron—Skin disorder—Etoposide—brain cancer	0.000757	0.00378	CcSEcCtD
Mirabegron—Nausea—Hydroxyurea—brain cancer	0.000741	0.0037	CcSEcCtD
Mirabegron—Asthenia—Carmustine—brain cancer	0.000723	0.00361	CcSEcCtD
Mirabegron—Asthenia—Temozolomide—brain cancer	0.000699	0.00349	CcSEcCtD
Mirabegron—Diarrhoea—Carmustine—brain cancer	0.00069	0.00344	CcSEcCtD
Mirabegron—Pruritus—Temozolomide—brain cancer	0.000689	0.00344	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Etoposide—brain cancer	0.000673	0.00336	CcSEcCtD
Mirabegron—Fatigue—Etoposide—brain cancer	0.000672	0.00335	CcSEcCtD
Mirabegron—Dizziness—Carmustine—brain cancer	0.000666	0.00333	CcSEcCtD
Mirabegron—Constipation—Etoposide—brain cancer	0.000666	0.00333	CcSEcCtD
Mirabegron—Diarrhoea—Temozolomide—brain cancer	0.000666	0.00333	CcSEcCtD
Mirabegron—Dizziness—Temozolomide—brain cancer	0.000644	0.00322	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etoposide—brain cancer	0.000637	0.00318	CcSEcCtD
Mirabegron—Rash—Carmustine—brain cancer	0.000635	0.00317	CcSEcCtD
Mirabegron—Dermatitis—Carmustine—brain cancer	0.000635	0.00317	CcSEcCtD
Mirabegron—Headache—Carmustine—brain cancer	0.000631	0.00315	CcSEcCtD
Mirabegron—Urticaria—Etoposide—brain cancer	0.000619	0.00309	CcSEcCtD
Mirabegron—Abdominal pain—Etoposide—brain cancer	0.000616	0.00308	CcSEcCtD
Mirabegron—Rash—Temozolomide—brain cancer	0.000614	0.00307	CcSEcCtD
Mirabegron—Dermatitis—Temozolomide—brain cancer	0.000614	0.00306	CcSEcCtD
Mirabegron—Headache—Temozolomide—brain cancer	0.00061	0.00305	CcSEcCtD
Mirabegron—Nausea—Carmustine—brain cancer	0.000599	0.00299	CcSEcCtD
Mirabegron—Nausea—Temozolomide—brain cancer	0.000578	0.00289	CcSEcCtD
Mirabegron—Asthenia—Etoposide—brain cancer	0.000559	0.00279	CcSEcCtD
Mirabegron—Pruritus—Etoposide—brain cancer	0.000551	0.00275	CcSEcCtD
Mirabegron—Diarrhoea—Etoposide—brain cancer	0.000533	0.00266	CcSEcCtD
Mirabegron—Dizziness—Etoposide—brain cancer	0.000515	0.00257	CcSEcCtD
Mirabegron—Rash—Etoposide—brain cancer	0.000491	0.00245	CcSEcCtD
Mirabegron—Dermatitis—Etoposide—brain cancer	0.000491	0.00245	CcSEcCtD
Mirabegron—Headache—Etoposide—brain cancer	0.000488	0.00244	CcSEcCtD
Mirabegron—Nausea—Etoposide—brain cancer	0.000463	0.00231	CcSEcCtD
